Our CEO Immanuel Lerner will be attending & presenting at the NextGen Biomed 2025 in London, March 12-13
Join our CEO, Immanuel Lerner for insights on AI-driven peptide drug discovery:📅 March 12:🗝 Keynote – Orally Available Peptides | 9:55 AM💡 Panel – Novel Peptide Therapeutics | 12:30 PM 📅 March 13:🎙 Moderator – Optimizing Drug Candidates | 2:15 PM
Our CEO and co-founder, Dr. Immanuel Lerner and our Advisory Board Member, Dr. Sarah Benson-Konforty will attend the J.P. Morgan Global Healthcare Conference
Join them at the J.P. Morgan 43rd Annual Healthcare Conference 2025, which will take place 13-16 January 2025 in San Francisco, CA, USA.Mr. Lerner will also participate in the Executive Roundtable Wuxi Global Forum, and host a table on Jan 14th from 5-6pm PST. You can reserve a spot here >> https://lnkd.in/d6qhfYWi
Our COO Maayan Elias Robicsek will attend Biomed Israel 2025, May 21-23/2024
Our COO Maayan Elias Robicsek is attending Biomed Israel 2025! Come and say hello to learn about our AI drug discovery platform
Visit us at BIOMED Israel May 16-18
Join us at booth #3 in the Start-Up Pavilion on May 16th, at BIOMED 2023, Israel’s largest life sciences conference.
Our CEO and co-founder, Dr. Immanuel Lerner will be speaking at TIDES Asia 2023
Dr. Immanuel Lerner, CEO and co-founder of Pepticom, will speak at the TIDES Asia conference between March 7-9. His lecture will be about The Potential and Current Application of Artificial Intelligence in Peptide Drug Discovery. The conference will take place in Kyoto, from March 7-9, and he will be available for meetings there as well […]